Below is a comprehensive list of all our COVID-19 research products broken down into main product categories:
COVID-19 Research Products (Proteins, Antibodies, ELISA and cDNA)
Use the buttons below to view specific suppliers Variants Proteins
Use the buttons below to view specific suppliers Omicron Variant Proteins
| Supplier | Name | Code | Expression Host |
| Sino Biological | NEW SARS-CoV-2 VOC Spike RBD (N501Y)-His Recombinant Protein | 40592-V08H82 | HEK293 |
| Lubio |
Recombinant trimeric SARS-CoV-2 Spike Protein | LU2010 | CHOExpressTM cells |
| Signalchem | Recombinant 2019-nCoV Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) | C19SD-G241F | CHO cells |
| Signalchem | Recombinant SARS-CoV-2 Coronavirus (COVID-19) Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) C-terminal his tag | C19SD-G241H | CHO cells |
| Signalchem | 2019-nCoV Spike RBD-N Protein Chimera | C19NSD-G242H | CHO cells |
| Signalchem | Recombinant 2019-nCoV Spike protein S1 (16-685) | C19S1-G241H | CHO cells |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike Protein (RBD, Fc Tag) | 40592-V02H | HEK293 Cells |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike Protein (RBD, His Tag) | 40592-V08B | HEK293 Cells |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike Protein (RBD, His Tag) | 40592-V08H | Baculovirus-Insect Cells |
| Sino Biological | SARS-CoV-2Coronavirus COVID-19 Spike Protein (RBD, rabbitFc Tag) | 40592-V31H | HEK293 Cells |
| Genetex | SARS-CoV-2 (COVID-19) Spike S1 protein, His tag (active) | GTX01554-pro | |
| Genetex | SARS-CoV-2 (COVID-19) Spike S1 protein, His tag (active) | GTX135817-pro | |
| Genetex | SARS-CoV-2 (COVID-19) Spike S2 (ECD) protein, human IgG Fc tag | GTX01559-pro | |
| Genetex | SARS-CoV-2 (COVID-19) nucleocapsid protein | GTX135592-pro | |
| Cusabio | SARS-CoV-2 Recombinant Human Novel Coronavirus Nucleoprotein(N) | CSB-MP3325GMY | Mammalian cell |
| Cusabio | SARS-CoV-2 Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial16-685aa | CSB-YP3324GMY | Yeast |
| Cusabio | SARS-CoV-2 Recombinant Human Novel Coronavirus Nucleoprotein(N) | CSB-YP3325GMY | Yeast |
| Cusabio | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial 319-541aa | CSB-YP3324GMY1 | Yeast |
| Cusabio | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial 319-541aa | CSB-MP3324GMY1 | Mammalian cell |
| Bioss | Recombinant SARS-CoV-2 Spike RBD | bs-46003P | HEK293 |
| Bioss | Biotinylated Recombinant SARS-CoV-2 Spike RBD | bs-46003P-Biotin | HEK293 |
| Bioss | Recombinant SARS-CoV-2 Spike RBD | bs-46005P | HEK293 |
| Bioss | Recombinant SARS-CoV-2 Spike S1 | bs-46004P | HEK293 |
| Bioss | Biotinylated Recombinant SARS-CoV-2 Spike S1 | bs-46004P-Biotin | HEK293 |
| Bioss | Recombinant SARS-CoV-2 Spike S1 | bs-46006P | HEK293 |
Use the buttons below to view specific suppliers Variants Proteins
Or browse the table below;
| Catalogue No. | Antigen | Mutation |
| Recombinant Mutants from the Omicron Variant | B.1.1.529 | ||
| C19SD-G231OH | S1 | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H |
| C19S1-G231OH | RBD | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H |
| 40589-V08H26 | S-ECD | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F |
| 40589-V08B33 | S-ECD | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F |
| 40592-V49H7 | RBD | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H |
| 40589-V49H3-B | S-ECD | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F |
| 40592-V08H121 | RBD | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H |
| 40592-V49H7-B | RBD | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H |
| 40591-V08H41 | S1 | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H |
| 40588-V07E34 | N | P13L, E31del, R32del, S33del, R203K, G204R |
| CSB-MP3324GMY(M7) | S | 16-685aa(A67V, Δ69-70, T95I, G142D, Δ143-145, Δ211, L212I, ins214-215EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H); |
| CSB-MP3324GMY1(M14) | S | 319-541aa(G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H); |
| CSB-MP3324GMY9(M) | S | 13-303aa(A67V, Δ69-70, T95I, G142D, Δ143-145, ΔN211, L212I, ins214EPE); |
| CSB-MP3325GMY(M18) | N | 1-419aa(P13L, Δ31-33, R203K, G204R) |
| Recombinant Mutants from the Indian Variant | B.1.617 | ||
| 40588-V07E20 | N | R203M, D377Y |
| 40588-V07E29 | N | D63G, R203M, D377Y |
| 40592-V08H91 | RBD | T478K |
| 40589-V08B12 | S1+S2 | E154K, L452R, E484Q, D614G, P681R, E1072K, K1073R |
| 40592-V02H3 | RBD | L452R, T478K |
| 40592-V08H88 | RBD | L452R，E484Q |
| 40592-V08H28 | RBD | L452R |
| 40591-V08H19 | S1 | D614G, E154K, E484Q, L452R, P681R |
| 40592-V08H81 | RBD | E484Q |
| 40588-V07E16 | N | D377Y |
| Recombinant Mutants from the U.K. Variant | B.1.1.7 | ||
| 40592-V08H82 | RBD | N501Y |
| 40592-V08H82-B | RBD-Biotinylated | N501Y |
| 40591-V08H7 | S1 | HV69-70 deletion, N501Y, D614G |
| 40591-V08H12 | S1 | H69del, V70del, Y144del, N501Y, A570D, D614G, P681H |
| 40588-V07E7 | N | D3L, R203K, G204R, S235F |
| 40588-V07E8 | N | D3L, S235F |
| 40589-V08B6 | S-ECD | H69del, V70del, Y144del, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H |
| B.1.1.7 (Alpha) Spike Proteins | ||
| GTX136059-pro | Spike | del69-70, del144, N501Y, A570D, D614G, P681H,T716I, S982A, D1118H (ECD) Protein, His tag (active) |
| GTX136014-pro | Spike RBD | N501Y Mutant protein, His tag (active) |
| GTX136058-pro | Spike RBD | E484K, N501Y Mutant protein, His tag (active) |
| GTX136023-pro | Spike S2 | T716I, S982A, D1118H Mutant (ECD) protein, His tag |
| GTX136085-pro | Spike S1 | del69-70, del144, N501Y, A570D, D614G, P681H Mutant protein, His tag |
| B.1.617.2 (Delta) Spike Proteins | ||
| GTX136332-pro | Spike RBD | B.1.617.2 (Delta) L452R, T478K Mutant Protein, His tag (active) |
| GTX136299-pro | RBD | B.1.617.1 (Kappa) L452R, E484Q Mutant protein, His tag (active) |
| GTX136333-pro | RBD | AY.1 (Delta plus)K417N, L452R, T478K, Mutant Protein His tag |
| In Production | Spike | T19R, G142D, del156-157, R158G, L452R, T478K, D614G, P681R, D950N) (ECD) Protein, His tag (active) |
| Recombinant Mutants from the Brazil Variant | P.1 | ||
| 40592-V08H82 | RBD | N501Y |
| 40592-V08H84 | RBD | E484K |
| 40592-V08H86 | RBD | K417T, E484K, N501Y |
| Recombinant Mutants from the South Africa Variant | B.1.351 | ||
| 40592-V08H82 | RBD | N501Y |
| 40592-V08H84 | RBD | E484K |
| 40592-V08H59 | RBD | K417N |
| 40592-V08H85 | RBD | K417N, E484K, N501Y |
| 40591-V08H10 | S1 | K417N, E484K, N501Y, D614G |
| B.1.351 (Beta) Spike Proteins | ||
| GTX136061-pro | Spike | L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G, A701V Mutant (ECD) protein, His tag |
| GTX136022-pro | Spike RBD | K417N, E484K, N501Y Mutant protein, His tag (active) |
| GTX136095-pro | Spike S1 | L18F, D80A,…, R246I, K417N, E484K, N501Y, D614G, His tag (active) |
| P.1 (Gamma) Spike Proteins | ||
| GTX136091-pro | Spike | (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F Mutant) (ECD) protein, His tag |
| GTX136043-pro | Spike RBD | Spike RBD (K417T, E484K, N501Y Mutant) protein, His tag (active) |
| GTX136094-pro | Spike S1 | Spike S1 (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G Mutant) protein, His tag |
| Recombinant Mutants from the Denmark Mink Variant | ||
| 40592-V08H80 | RBD | Y453F |
| 40591-V08H8 | S1 | ΔH69/ΔV70, Y453F, D614G |
| 40592-V08H86 | RBD | K417T, E484K, N501Y |
| High Frequency Mutation of Nucleocapsid | ||
| 40588-V07E1 | N | R203K, G204R |
| 40588-V07E2 | N | P13L |
| 40588-V07E3 | N | S194L |
| 40588-V07E4 | N | I292T |
| Supplier | Name | Code |
| Signalchem | Anti 2019-nCoV Spike Protein Llama heavy-chain Nanobody – Human IgG Fc | C19S1-641HL |
| Signalchem | Anti-2019-nCoV N-Protein Recombinant Human Monoclonal Antibody | C19NP-60H |
| Signalchem | Anti-2019-nCoV Spike Protein Antibody HRP conjugated | C19S1-60DH |
| Signalchem | Anti-2019-nCoV Spike (SC0175) Recombinant Human Monoclonal Antibody | C19S1-60H |
| Genetex | SARS-CoV-2 Coronavirus (COVID-19) nucleocapsid antibody | GTX135357 |
| Genetex | SARS-CoV-2 (COVID-19) spike antibody | GTX135356 |
| Genetex | SARS-CoV / SARS-CoV-2 Coronavirus (COVID-19) nucleocapsid antibody [6H3] | GTX632269 |
| Genetex | SARS-CoV / SARS-CoV-2 Coronavirus (COVID-19) spike antibody [1A9] | GTX632604 |
| Genetex | SARS-CoV-2 (COVID-19) nucleocapsid antibody [HL146] | GTX635680 |
| Genetex | SARS-CoV-2 (COVID-19) Spike S1 antibody [HL1] | GTX635656 |
| Genetex | SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022] | GTX01555 |
| BioSS | Coronavirus COVID-19 SARS-CoV-2 Nucleocapsid Protein Monoclonal Antibody (6A8) | bsm-41413M |
| BioSS | Coronavirus COVID-19 SARS-CoV-2 Nucleocapsid Protein Monoclonal Antibody (7E1B) | bsm-41414M |
| BioSS | Coronavirus COVID-19 SARS-CoV-2 Nucleocapsid Protein Monoclonal Antibody (14B2D) | bsm-41415M |
| BioSS | Coronavirus COVID-19 SARS-CoV-2 Nucleocapsid Protein Polyclonal Antibody | bs-41408R |
| Cusabio | SARS-CoV-2 Spike glycoprotein(S) Antibody, partial(16-685aa) | CSB-RA33245A0GMY |
| Cusabio | SARS-CoV-2 Spike glycoprotein(S) Antibody (16-685aa) | CSB-RA33245A1GMY |
| Cusabio | SARS-CoV-2 Nucleoprotein Antibody (1-419aa) | CSB-RA33255A0GMY |
| Cusabio | SARS-CoV-2 Nucleoprotein(N) Antibody (1-419aa) | CSB-RA33255A1GMY |
| Sino Biological | SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Mouse MAb | 40143-MM08 |
| Sino Biological | SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb | 40143-R040 |
| Sino Biological | SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb | 40143-R004 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike S2 Antibody, Chimeric Mab | 40590-D001 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike RBD Antibody, Rabbit PAb | 40592-T62 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike S2 Antibody, Rabbit PAb | 40590-T62 |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike Antibody, Rabbit Mab | 40150-R007 |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Nucleoprotein / NP Antibody, Rabbit Mab | 40143-R019 |
| Elabscience | SARS-COV/SARS-COV-2 Spike Monoclonal Antibody(2019-nCoV) | E-AB-V1001 |
| Elabscience | SARS-COV/SARS-COV-2 Spike S1 Monoclonal Antibody(2019-nCoV) | E-AB-V1005 |
| Elabscience | SARS-COV/SARS-COV-2 Spike RBD Polyoclonal Antibody(2019-nCoV) | E-AB-V1006 |
| Elabscience | SARS-COV/SARS-COV-2 NP Monoclonal Antibody(2019-nCoV) | E-AB-V1011 |
| Elabscience | SARS-COV/SARS-COV-2 NP ScFv Monoclonal Antibody(2019-nCoV) | E-AB-V1012 |
| Supplier | Name | Code |
| Genetex | SARS-CoV / SARS-CoV-2 Coronavirus(COVID-19) ORF7a antibody [3C9] | GTX632602 |
| Genetex | SARS-CoV / SARS-CoV-2 Coronavirus (COVID-19) NSP8 antibody [5A10] | GTX632696 |
| Genetex | ACE2 antibody [SN0754] Rabbit Monoclonal | GTX01160 |
| Genetex | ACE2 antibody [SN0754] Rabbit Monoclonal | GTX01160 |
| Genetex | ACE2 antibody [N1N2], N-term | GTX101395 |
| Genetex | TMPRSS2 antibody [N2C3] | GTX100743 |
| Genetex | ACE2 antibody | GTX15349 |
| Genetex | ACE2 antibody [N1N2], N-term | GTX101395 |
| Genetex | TMPRSS2 antibody [N2C3] | GTX100743 |
| BioSS | ACE2 rabbit polyclonal antibody | bs-23027R |
| BioSS | ACE2 rabbit polyclonal antibody | bs-23028R |
| BioSS | ACE2 rabbit polyclonal antibody | bs-23443R |
| BioSS | ACE2 rabbit polyclonal antibody | bs-23444R |
| Bioss | Angiotensin Converting Enzyme 2 (3F1) ACE2 Rabbit Monoclonal Antibody | bsm-52614R |
| Cusabio | ACE2 Antibody | CSB-PA866317LA01HU |
| Cusabio | ACE2 Antibody | CSB-PA001150GA01HU |
| Sino Biological | Human ACE2 / Angiotensin-Converting Enzyme 2 Antibody, Rabbit Pab | 10108-RP01 |
| Sino Biological | Human ACE2 / Angiotensin-Converting Enzyme 2 Antibody, Rabbit PAb, Antigen Affinity Purified | 10108-RP01 |
| Elabscience | ACE2 Polyclonal Antibody | E-AB-12224 |
| Supplier | Name | Code |
| Signalchem | Anti 2019-nCoV Spike Protein Llama heavy-chain Nanobody – Human IgG Fc | C19S1-641HL |
| Signalchem | Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-652L |
| Signalchem | Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-654L |
| Signalchem | Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20038) | C19S1-642HL |
| Signalchem | Anti-2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-653L |
| Signalchem | Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20025) | C19S1-643HL |
| Signalchem | Anti 2019-nCoV Spike Protein Neutralizing Nanobody (NBX20014) | C19S1-644HL |
| Sino Biological | Anti-Spike S1, Mouse Monoclonal IgG1 Neutralizing Antibody | 40591-MM43 |
| Sino Biological | Anti-Spike RBD, Mouse Monoclonal IgG2b Neutralizing Antibody | 40592-MM57 |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Spike Neutralizing Antibody, Rabbit Mab | 40592-R001 |
| Cusabio | SARS-CoV-2 Spike Neutralizing Antibody (16-685aa) chimeric clone H6 MAb | CSB-RA33245A1GMY |
| Cusabio | SARS-CoV-2 Spike RBD (319-541aa) Neutralizing Nanobody clone A1 MAb | CSB-RA33245A2GMY |
| Genetex | SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022] | GTX01555 |
| Genetex | SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022-RB] | GTX01556 |
| Catalog No. | Antibody Type | Dilution | Volume/QTY |
| ACE2 – MMab | |||
| BSB-3702-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3702-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3702-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3702-01 | Concentrated | 1:25-1:100 | 0.1 ml |
| BSB-3702-05 | Concentrated | 1:25-1:100 | 0.5 ml |
| BSB-3702-1 | Concentrated | 1:25-1:100 | 1.0 ml |
| BSB-3702-CS | Control Slides | 5 | |
| CD147 – MMab | |||
| BSB-3704-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3704-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3704-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3704-01 | Concentrated | 1:50-1:200 | 0.1 ml |
| BSB-3704-05 | Concentrated | 1:50-1:200 | 0.5 ml |
| BSB-3704-1 | Concentrated | 1:50-1:200 | 1.0 ml |
| BSB-3704-CS | Control Slides | 5 | |
| IL-1a – MMab | |||
| BSB-3705-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3705-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3705-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3705-01 | Concentrated | 1:50-1:200 | 0.1 ml |
| BSB-3705-05 | Concentrated | 1:50-1:200 | 0.5 ml |
| BSB-3705-1 | Concentrated | 1:50-1:200 | 1.0 ml |
| BSB-3705-CS | Control Slides | 5 | |
| IL-1b – MMab | |||
| BSB-3706-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3706-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3706-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3706-01 | Concentrated | 1:50-1:200 | 0.1 ml |
| BSB-3706-05 | Concentrated | 1:50-1:200 | 0.5 ml |
| BSB-3706-1 | Concentrated | 1:50-1:200 | 1.0 ml |
| BSB-3706-CS | Control Slides | 5 | |
| IL-6 – MMab | |||
| BSB-3707-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3707-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3707-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3707-01 | Concentrated | 1:50-1:200 | 0.1 ml |
| BSB-3707-05 | Concentrated | 1:50-1:200 | 0.5 ml |
| BSB-3707-1 | Concentrated | 1:50-1:200 | 1.0 ml |
| BSB-3707-CS | Control Slides | 5 | |
| SARS-CoV-2 – MMab | |||
| BSB-3701-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3701-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3701-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3701-01 | Concentrated | 1:25-1:100 | 0.1 ml |
| BSB-3701-05 | Concentrated | 1:25-1:100 | 0.5 ml |
| BSB-3701-1 | Concentrated | 1:25-1:100 | 1.0 ml |
| BSB-3701-1-CS | Control Slides | 5 | |
| TMPRSS2 | |||
| BSB-3703-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3703-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3703-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3703-01 | Concentrated | 1:50-1:200 | 0.1 ml |
| BSB-3703-05 | Concentrated | 1:50-1:200 | 0.5 ml |
| BSB-3703-1 | Concentrated | 1:50-1:200 | 1.0 ml |
| BSB-3703-CS | Control Slides | 5 | |
| TNFa-IP2 | |||
| BSB-3708-3 | Prediluted | Ready-To-Use | 3.0 ml |
| BSB-3708-7 | Prediluted | Ready-To-Use | 7.0 ml |
| BSB-3708-15 | Prediluted | Ready-To-Use | 15.0 ml |
| BSB-3708-01 | Concentrated | 1:50-1:200 | 0.1 ml |
| BSB-3708-05 | Concentrated | 1:50-1:200 | 0.5 ml |
| BSB-3708-1 | Concentrated | 1:50-1:200 | 1.0 ml |
| BSB-3708-CS | Control Slides | 5 |
| Supplier | Product name | Code |
| Signalchem | Anti-2019-nCoV Spike (mFc) Recombinant mAb with human Fab and mouse Fc region | C19S1-61MH |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6 | CSB-RA33245A0GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6 | CSB-RA33245A0GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6 – Neutralising | CSB-RA33245A1GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6 – Neutralising | CSB-RA33245A1GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6 – HRP conjugated | CSB-RA33245B1GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6 – HRP conjugated | CSB-RA33245B1GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6, FITC conjugated | CSB-RA33245C1GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6, FITC conjugated | CSB-RA33245C1GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6, Biotin conjugated | CSB-RA33245D1GMY |
| Cusabio | SARS-CoV-2 S Antibody (16-685aa) chimeric clone H6, Biotin conjugated | CSB-RA33245D1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6 | CSB-RA33255A0GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6 | CSB-RA33255A0GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6 | CSB-RA33255A1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6 | CSB-RA33255A1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6, HRP conjugated | CSB-RA33255B1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6, HRP conjugated | CSB-RA33255B1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6, FITC conjugated | CSB-RA33255C1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6, FITC conjugated | CSB-RA33255C1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6, Biotin conjugated | CSB-RA33255D1GMY |
| Cusabio | SARS-CoV-2 N Antibody (1-419aa) chimeric clone 1A6, Biotin conjugated | CSB-RA33255D1GMY |
| Sino | SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric Mab clone D001 | 40150-D001 |
| Sino | SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric Mab clone D002 | 40150-D002 |
| Sino | SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric Mab clone D003 | 40150-D003 |
| Sino | SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric Mab clone D004 | 40150-D004 |
| Sino | SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric Mab clone D005 | 40150-D005 |
| Sino | SARS-CoV/SARS-CoV-2 Spike Antibody, Chimeric Mab clone D006 | 40150-D006 |
| Sino | SARS-CoV-2 (2019-nCoV) Spike S2 Antibody, Chimeric Mab clone D001 | 40590-D001 |
| Sino | SARS-CoV-2 (2019-nCoV) Spike antibody (HRP), Chimeric Mab clone D001 | 40150-D001-H |
| Description | Conjugate | Code |
|---|---|---|
| Goat Anti-Human IgG (H+L) (min X Bov, Hrs, Ms Sr Prot) | Unconjugated | 109‑005‑088 |
| HRP | 109‑035‑088 | |
| Biotin | 109‑065‑088 | |
| Goat Anti-Human IgG, Fcγ fragment specific | Unconjugated | 109‑005‑008 |
| HRP | 109‑035‑008 | |
| Biotin | 109‑065‑008 | |
| Goat Anti-Human IgG, Fcγ fragment specific (min X Bov, Ms Sr Prot) | Unconjugated | 109‑005‑190 |
| HRP | 109‑035‑190 | |
| Biotin | 109‑065‑190 | |
| Goat Anti-Human IgG, Fcγ fragment specific (min X Bov, Hrs, Ms Sr Prot) | Unconjugated | 109‑005‑098 |
| HRP | 109‑035‑098 | |
| Biotin | 109‑065‑098 | |
| R-PE | 109‑115‑098 | |
| Goat Anti-Human IgG + IgM (H+L) (min X Bov Sr Prot) | Unconjugated | 109‑005‑127 |
| HRP | 109‑035‑127 | |
| Biotin | 109‑065‑127 | |
| Goat Anti-Human IgM, Fc5μ fragment specific (min X Bov Sr Prot) | Unconjugated | 109‑005‑129 |
| HRP | 109‑035‑129 | |
| Biotin | 109‑065‑129 | |
| F(ab’)2 Fragment Goat Anti-Human IgG, Fcγ fragment specific (min X Bov, Hrs, Ms Sr Prot) | Unconjugated | 109‑006‑098 |
| HRP | 109‑036‑098 | |
| Biotin | 109‑066‑098 | |
| R-PE | 109‑116‑098 | |
| F(ab’)2 Fragment Goat Anti-Human IgG, Fcγ fragment specific (min X Bov, Ms, Rb Sr Prot) | Unconjugated | 109‑006‑098 |
| HRP | 109‑036‑098 | |
| Biotin | 109‑066‑098 | |
| R-PE | 109‑116‑098 | |
| Donkey Anti-Human IgG, Fcγ fragment specific (min X Bov, Hrs, Ms Sr Prot) | Unconjugated | 709‑005‑098 |
| HRP | 709‑035‑098 | |
| Biotin | 709‑065‑098 | |
| Donkey Anti-Human IgM, Fc5μ fragment specific (min X Bov, Hrs Sr Prot) | Unconjugated | 709‑005‑073 |
| HRP | 709‑035‑073 | |
| Biotin | 709‑065‑073 |
| Supplier | Name | Code | Expression Host |
| Signalchem | Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (19-740) | A51C2-G341F | CHO cells |
| Signalchem | Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (18-615) | A51C2-G342F | CHO cells |
| Signalchem | 2019-nCoV RdRp, Active | C19RP-G241H | E coli |
| Signalchem | Recombinant 2019-nCoV PLpro/papain-like protease, part of a large replicase polyprotein 1ab (E1564-Y1882) – his tag | C19PL-G241H | E coli |
| Signalchem | 2019-nCoV 3CLpro, Active | C19CL-G241H | E coli |
| Signalchem | Cas12(LbCpf1) Protein | C12CR-G241G | E coli |
| Genetex | Human ACE2 protein, His and Avi tag | GTX01550-pro | |
| Genetex | SARS-CoV-2 (COVID-19) Envelope protein, His and Avi tag | GTX01547-pro | |
| Genetex | SARS-CoV-2 (COVID-19) Envelope Protein, GST and His Tag | GTX01565-pro | |
| Genetex | SARS-CoV-2 (COVID-19) 3CLpro (nsp5) protein, His and Avi tag | GTX01557-pro | |
| Cusabio | Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial 18-740aa | CSB-AP005671HU | Mammalian cell |
| Cusabio | Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial 18-740aa | CSB-MP866317HU | Mammalian cell |
| Cusabio | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial 18-740aa | CSB-AP005671HU | Mammalian cell |
| Cusabio | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial 18-740aa | CSB-MP866317HU | Mammalian cell |
| Bioss | Recombinant Human ACE2 | bs-46001P | HEK293 |
| Bioss | Recombinant Human ACE2 | bs-46002P | HEK293 |
| Supplier | Name | Code |
|
Salimetrics
|
Salivary Covid-19 (Sars-Cov-2, N) IgG Elisa Kit – From Saliva Samples
|
|
| Signalchem | 2019-nCoV S1 Protein ELISA Kit | C19SD-876 |
| Signalchem | 2019-nCoV S1 Human IgG ELISA Kit | C19S1-877 |
| Signalchem | 2019-nCoV S1 Human IgA ELISA Kit | C19S1-A877 |
| Signalchem | 2019-nCoV S1 Human IgM ELISA Kit | C19S1-M877 |
| Signalchem | 2019-nCoV S1 Human IgG-IgA-IgM ELISA Kit | C19S1-P877 |
| Signalchem | 2019-nCoV N-S1 Human IgG-IgA-IgM ELISA Kit | C19NS1-P877 |
| Signalchem | 2019-nCoV N-S1 Human IgA ELISA Kit | C19NS1-A877 |
| Signalchem | 2019-nCoV N-S1 Human IgM ELISA Kit | C19NS1-M877 |
| Signalchem | 2019-nCoV N-S1 Human IgG ELISA Kit | C19NS1-877 |
| Signalchem | 2019-nCoV High Sensitivity S1 Protein ELISA KIT | C19S1-876 |
| Signalchem | 2019-nCoV Neutralization ELISA KIT | C19SD-N887 |
| Cusabio | Human SARS-CoV-2 S1 RBD IgM Antibody ELISA Kit | CSB-EL33242HU |
| Cusabio | SARS-CoV-2 N ELISA Kit | CSB-EL33251 |
| Cusabio | SARS-CoV-2 S1 RBD ELISA Kit | CSB-EL33244 |
| Cusabio | SARS-CoV-2 N IgG Antibody ELISA Kit | CSB-EL3325HU |
| Cusabio | SARS-CoV-2 S RBD Ab (IgG) ELISA kit | CSB-EL33241HU |
| Cusabio | SARS-CoV-2 N/S1 Ab (IgG) ELISA kit | CSB-EL3326HU |
| Supplier | Name | Code |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Nucleoprotein / NP ORF mammalian expression plasmid 1260bp | VG40588-UT |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike ORF mammalian expression plasmid 3822bp | VG40589-UT |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike(RBD) ORF mammalian expression plasmid 675bp | VG40592-UT |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike(S2) ORF mammalian expression plasmid 1770bp | VG40590-UT |
| Sino Biological | SARS-CoV-2 Coronavirus COVID-19 Spike(S1) ORF mammalian expression plasmid 2058bp | VG40591-UT |
| Sino Biological | SARS-CoV-2 (2019-nCoV) 3C-like proteinase/3CLpro Gene ORF cDNA clone expression plasmid | VG40594-UT |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Helicase/HE Gene ORF cDNA clone expression plasmid | VG40596-UT |
| Sino Biological | SARS-CoV-2 (2019-nCoV) EndoRNAse/EN Gene ORF cDNA clone expression plasmid | VG40597-UT |
| Sino Biological | SARS-CoV-2 (2019-nCoV) Methyltransferase/ME Gene ORF cDNA clone expression plasmid | VG40598-UT |
| Sino Biological | SARS-CoV-2 (2019-nCoV) NSP10 Gene ORF cDNA clone expression plasmid | VG40599-UT |
| System Biosciences | pPACK-SPIKE N501Y SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix | CVD19-560A-1 |
| System Biosciences | pPACK-SPIKE N501Y Combo Kit, includes Cat# CVD19-560A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) | CVD19-575A-KIT |
| System Biosciences | pPACK-SPIKE™ SARS-CoV-2 “S” Pseudotype Lentivector Packaging Mix | CVD19-510A-1 |
| System Biosciences | pPACK-SPIKE D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix | CVD19-530A-1 |
| System Biosciences | pPACK-SPIKE D614G Combo Kit, with PureFection Transfection Reagent and PEG-it Virus Concentration solution | CVD19-550A-KIT |
| System Biosciences | pPACK-SPIKE Combo Kit, with PureFection Transfection Reagent and PEG-it Virus Concentration solution | CVD19-520A-KIT |
| System Biosciences | SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector | CVD19-120PA-1 |
| System Biosciences | SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector Plasmid | CVD19-135PA-1 |
| System Biosciences | SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector Plasmid | CVD19-130PA-1 |
| System Biosciences | ACE2 Expression Lentivector Plasmid | CVD19-100PA-1 |
| System Biosciences | SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector pre-pacakaged Lentivirus | CVD19-135VA-1 |
| System Biosciences | SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector pre-pacakaged Lentivirus | CVD19-130VA-1 |
| System Biosciences | ACE2 Expression Expression Lentivector pre-pacakaged Lentivirus | CVD19-100VA-1 |
| Supplier | Name | Code |
| YouSeq | SARS-CoV-2 Coronavirus COVID-19 NGS library prep kit for Illumina sequencing | YS-NGS-nCoV19-IL-96 |
| YouSeq | SARS-CoV-2 Coronavirus COVID-19 NGS library prep kit for Ion Torrent sequencing | YS-NGS-nCoV19-IT-96 |
Compound Library
| Supplier | Code | Name |
| ApexBio | L1050 | DiscoveryProbe™ Anti-Virus Compound Library (List of compounds) |
| ApexBio | L1021 | DiscoveryProbe™ FDA-approved Drug Library (List of compounds) |
Coronavirus proteases substrates
| Supplier | Code | Name |
| AAT | 13542 | Covidyte™ IF670 – Coronavirus protease fluorescent substrate |
| AAT | 13543 | Covidyte™ IF670 – Coronavirus protease fluorescent substrate |
| AAT | 13538 | Covidyte™ ED450 – Coronavirus protease fluorescent substrate |
| AAT | 13537 | Covidyte™ ED450 – Coronavirus protease fluorescent substrate |
| AAT | 13536 | Covidyte™ EN450 – Coronavirus protease fluorescent substrate |
| AAT | 13535 | Covidyte™ EN450 – Coronavirus protease fluorescent substrate |
| AAT | 13540 | Covidyte™ TF670 – Coronavirus protease fluorescent substrate |
| AAT | 13541 | Covidyte™ TF670 – Coronavirus protease fluorescent substrate |
ACE2 substrates for screening ACE2 inhibitors.
Individual Inhibitors
| Supplier | Code | Name | Supplier | Code | Name |
| Apex | B4874 | Hydroxychloroquine Sulfate | Signalchem | V115-905 | Bafilomycin A1 |
| Apex | A8628 | Chloroquine diphosphate | Signalchem | S565-906 | Camostat Mesilate |
| Apex | B8398 | Remdesivir (GS-5734) | Signalchem | A51-906 | Captopril |
| Apex | B3477 | Ciclesonide | Signalchem | S35-908 | Losartan potassium |
| Apex | B2285 | Daunorubicin HCl | Signalchem | I23-905 | Mycophenolic acid |
| Apex | A8458 | Lamivudine | Signalchem | S54-900 | Niclosamide |
| Apex | N2643 | Shikonin | Signalchem | C119-905-05 | Chloroquine phosphate |
| Apex | A8204 | Lopinavir | Signalchem | P312-905-10 | Nitazoxanide |
| Apex | A8203 | Ritonavir | Signalchem | T860-905-250 | Hydroxychloroquine |
| Apex | A2813 | Ivermectin | Signalchem | V113-908-10 | Valinomycin |
| Apex | A5275 | Tenofovir | Signalchem | V114-908-1000 | Verapamil HCl |
| Apex | B1123 | Rosuvastatin | |||
| Apex | A8206 | Darunavir | |||
| Apex | A2548 | Carmofur | |||
| Apex | B2078 | Atovaquone |
| Supplier | Product name | Code | Expression Host |
| System Biosciences | HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line | CVD19-220A-1 | HEK293 |
| System Biosciences | HEK293 ACE2 Stable Cell Line | CVD19-200A-1 | HEK293 |
| Signalchem | Human ACE2 Stable Cell line-CHO | A51C2-71C | CHO cells |
| Creative Diagnostics | Human ACE2 Expressing Stable Cell Line | CSC-ACE01 | HEK293T |
| Elabscience | VERO C1008 [Vero E6] cell line | EP-CL-0491 | |
| Elabscience | Vero Cell Line | EP-CL-0242 | |
| Elabscience | Calu-3 Cell Line | EP-CL-0054 | |
| Elabscience | HuH-7 Cell Line | EP-CL-0120 | |
| Elabscience | Caco-2 Cell Line | EP-CL-0050 | |
| Elabscience | 293T [HEK-293T] Cell Line | EP-CL-0005 | |
| Elabscience | LLC-MK2 cell line | EP-CL-0141 |
| Name | Catalog # | Type | Species | Applications | Size |
| ACE2-GFP Human Lung Airway Smooth Muscle Cells | HMC001 | Primary Cells | Cell Assays | 500,000 Cells | |
| ACE2-GFP Human Pulmonary Artery Endothelial Cells | HEC24 | Primary Cells | Human | Cell Assays | 500,000 Cells |
| ACE2-GFP Human Pulmonary Bronchial/Tracheal Epithelial Cells | HPEC003 | Primary Cells | Human | Cell Assays | 500,000 |
| ACE2-GFP Human Pulmonary Lobar Bronchial Epithelial Cells | HPEC001 | Primary Cells | Human | Cell Assays | 500,000 Cells |
| ACE2-GFP Human Pulmonary Small Airway Epithelial Cells | HPEC002 | Primary Cells | Human | Cell Assays | 500,000 Cells |
| Human Blood Brain Barrier Model | 3D45002 | 3D Cell/Tissue Models | Human | In vivo Like Assays | 12 well |
| Human Blood Brain Barrier Model | 3D45002 | 3D Cell/Tissue Models | Human | In vivo Like Assays | 24 well |
| Human Blood Brain Barrier Model | 3D45002 | 3D Cell/Tissue Models | Human | In vivo Like Assays | 6 well |
| Supplier | Product Name | Cat. Number |
| Dianova | Anti-SARS-CoV-2 (COVID-19) Spike S1 from Rabbit (HL134) – unconj. | IHC-184005 |
| Dianova | Anti-SARS-CoV-2 (COVID-19) Spike RBD from Rabbit (HL257) – unconj. | IHC-184006 |
| Dianova | Anti-SARS-CoV-2 (COVID-19) Spike S2 from Rabbit (HL1038) – unconj. | IHC-184007 |
| Dianova | Anti-SARS-CoV-2 (COVID-19) Spike S1 from Rabbit – unconj. | IHC-184008 |
Your first choice for scientific solutions
Find out more
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations